Haloperidol Related Compounds & Impurities

Haloperidol is a butyrophenone dopamine D2 receptor antagonist antipsychotic used for schizophrenia, acute psychosis and Tourette syndrome.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Haloperidol reference standards, pharmacopeial and non-pharmacopeial Haloperidol impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Haloperidol-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

Pharmaceutical Reference Standards / Impurity Standards

Haloperidol
Haloperidol Decanoate
Haloperidol Nonanoate
Dehydro Haloperidol
Haloperidol Impurity B Hydrochloride
Haloperidol EP Impurity D
N,C-Fluorophenylbutyryl Haloperidol
N,O-Fluorophenylbutyryl Haloperidol
Haloperidol Decanoate-3-Chlorobiphenyl Analog
Haloperidol Decanoate-3-Ethyl Analog
Haloperidol EP Impurity A
Haloperidol EP Impurity F
Haloperidol Decanoate EP Impurity C Hydrochloride
Haloperidol EP Impurity C
Haloperidol EP Impurity E Hydrochloride
Haloperidol EP Impurity E
Haloperidol N-Oxide
Reduced Haloperidol
4-Fluorobenzoic acid
Haloperidol Impurity 8
Bromperidol
Bromperidol Decanoate
Haloperidol Impurity 5
Haloperidol EP Impurity B
Haloperidol Cyclopropyl Derivative
Phenylperidol
Haloperidol Decanoate EP Impurity A
Haloperidol Decanoate EP Impurity B
Haloperidol Decanoate EP Impurity D
Haloperidol Decanoate EP Impurity E
Haloperidol Decanoate EP Impurity F
Haloperidol Decanoate EP Impurity H
Haloperidol Decanoate EP Impurity I
Haloperidol Decanoate EP Impurity J
Haloperidol Decanoate EP Impurity K
Haloperidol Decanoate EP Impurity L
4-Phenylpiperidine-4-ol
Haloperidol Impurity-8
Haloperidol Impurity 7
Haloperidol Decanoate N-Oxide
Cis-Haloperidol N-Oxide
Trans-Haloperidol N-Oxide
Haloperidol Impurity 11
Larotrectinib Impurity 1
Haloperidol Impurity 12
3-Chloro-4`-fluoropropiophenone
Haloperidol Impurity 13
6-Chloro-1-(4-Fluorophenyl)-1-Hexanone
4-Fluorophenacyl Chloride
7-Chloro-1-(4-Fluorophenyl)-1-Heptanone
Haloperidol Impurity C Hydrochloride
Haloperidol Decanoate EP impurity K Hydrochloride
Haloperidol Decanoate EP impurity J Hydrochloride
Haloperidol Decanoate EP impurity H Hydrochloride
Haloperidol Decanoate EP impurity I Hydrochloride
Haloperidol EP Impurity B Hydrochloride
Haloperidol EP Impurity A Hydrochloride
Haloperidol Decanoate EP Impurity B Hydrochloride
4-Chlorobutyrophenone
Haloperidol Impurity 14
Haloperidol Impurity 19
Haloperidol Decanoate N-Oxide (Cis-Isomer)
Haloperidol Decanoate-N-Oxide(Trans-Isomer)
Haloperidol Impurity 2

Metabolites

Haloperidol Glucuronide

Isotope Labelled Compounds

Haloperidol D4
Haloperidol-13C6